retatrutide dosage phase 2 trial Chart: 2mg to 12mg (Free PDF + Calculator) Peptide Series #3 — Retatrutide

Retatrutide has not been submitted to Health Canada, has no Notice of Compliance, and is not scheduled for Canadian prescription availability

Patients and healthcare professionals should exercise caution regarding unregulated sources

Those who received a placebo experienced a weight loss of 2.3%, with no plateau observed

Specific availability can vary based on geographic location and supply chains

While compounded medications are not FDA-approved, they are prepared according to strict standards and can be an effective option for many patients

The peptide exhibits anabolic and metabolic activities through IGF-1 receptor binding, though it has never been approved for therapeutic human use and remains confined to research applications [12]